Geneos Wealth Management’s Convergence Long/Short Equity ETF CLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.61K Sell
135
-94
-41% -$3.04K ﹤0.01% 2206
2026
Q1
$6.44K Buy
+229
New +$6.44K ﹤0.01% 2106

Other funds holding CLSE

Geneos Wealth Management's CLSE Position: Q2 2026 in Review

Geneos Wealth Management reduced its Convergence Long/Short Equity ETF (CLSE) stake by 41% in Q2 2026, selling an estimated $3.04K and leaving 135 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

Geneos Wealth Management first reported a position in CLSE in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.44K in Q1 2026. 116 funds tracked by Wall St. Rank hold CLSE as of Q2 2026.

  • Geneos Wealth Management held 135 shares of Convergence Long/Short Equity ETF worth $4.61K as of Q2 2026.
  • Geneos Wealth Management sold 94 Convergence Long/Short Equity ETF shares in Q2 2026, an estimated $3.04K.
  • Convergence Long/Short Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2206 holding.
  • Geneos Wealth Management first reported a position in Convergence Long/Short Equity ETF in Q1 2026 and has held it in 2 quarters since.
  • Geneos Wealth Management's Convergence Long/Short Equity ETF position peaked at $6.44K in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Convergence Long/Short Equity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.